Literature DB >> 9373273

Thrombosis and secondary hemochromatosis play major roles in the pathogenesis of jaundiced and spherocytic mice, murine models for hereditary spherocytosis.

T M Kaysser1, N J Wandersee, R T Bronson, J E Barker.   

Abstract

Jaundiced mice, ja/ja, suffer from a severe hemolytic anemia caused by a complete deficiency of erythroid beta-spectrin. We used these mice as a model to investigate the pathophysiological consequences of the deficiency, including the effects in the nonerythroid tissues where this protein is expressed. Because the ja/ja mice rarely survive beyond the fourth postnatal day, methods were assessed for extending lifespan into adulthood. Neonatal transfusion increased lifespan to a mean of 3.7 months, allowing a more complete characterization of the pathophysiology. Blood parameters and histopathology of the jaundiced mouse were compared with that from spherocytic mice, which have a hemolytic anemia caused by deficiency of erythroid alpha-spectrin, yet can survive the postnatal period transfusion free. The adult jaundiced and spherocytic mice present with greatly decreased hematocrit and red blood cell counts, reticulocytosis, and bilirubinemia, leading secondarily to hepatosplenomegaly and cardiomegaly. Jaundiced and spherocytic mice were analyzed histopathologically between 1.0 and 9.5 months of age. Interestingly, the complete absence of erythroid beta-spectrin in jaundiced mice leads to no detectable structural defects in brain, cardiac, or skeletal muscles. However, fibrotic lesions and lymphocytic infiltration were observed in cardiac tissue from 4 of 13 jaundiced mice and 15 of 15 spherocytic mice, and thrombi were detected at either the atrioventricular valves or within the atria of 2 of 13 jaundiced mice and 15 of 15 spherocytic mice. In addition, all affected mice had a progressive renal hemosiderosis concurrent with hydronephrosis and glomerulonephritis. The severity of the renal disease and its presence in all moribund mice suggests kidney failure rather than the fibrotic heart lesions as the major cause of death in these mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9373273

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

Review 1.  Does size matter in platelet production?

Authors:  Jonathan N Thon; Joseph E Italiano
Journal:  Blood       Date:  2012-06-04       Impact factor: 22.113

2.  The spectrin-based membrane skeleton stabilizes mouse megakaryocyte membrane systems and is essential for proplatelet and platelet formation.

Authors:  Sunita Patel-Hett; Hongbei Wang; Antonija J Begonja; Jonathan N Thon; Eva C Alden; Nancy J Wandersee; Xiuli An; Narla Mohandas; John H Hartwig; Joseph E Italiano
Journal:  Blood       Date:  2011-05-12       Impact factor: 22.113

3.  Rats provide a superior model of human stress erythropoiesis.

Authors:  Jingxin Zhang; Yijie Liu; Xu Han; Yang Mei; Jing Yang; Zheng J Zhang; Xinyan Lu; Peng Ji
Journal:  Exp Hematol       Date:  2019-09-25       Impact factor: 3.084

4.  Allogeneic bone marrow transplant in the absence of cytoreductive conditioning rescues mice with β-thalassemia major.

Authors:  Yongliang Huo; Jonathan R Lockhart; Shanrun Liu; Suean Fontenard; Mike Berlett; Thomas M Ryan
Journal:  Blood Adv       Date:  2017-11-28

5.  Spectrin-based pathways underlying electrical and mechanical dysfunction in cardiac disease.

Authors:  Sathya D Unudurthi; Amara Greer-Short; Nehal Patel; Drew Nassal; Thomas J Hund
Journal:  Expert Rev Cardiovasc Ther       Date:  2017-12-26

6.  Ankyrin and band 3 differentially affect expression of membrane glycoproteins but are not required for erythroblast enucleation.

Authors:  Peng Ji; Harvey F Lodish
Journal:  Biochem Biophys Res Commun       Date:  2011-12-27       Impact factor: 3.575

Review 7.  Non-proliferative and Proliferative Lesions of the Cardiovascular System of the Rat and Mouse.

Authors:  Brian R Berridge; Vasanthi Mowat; Hirofumi Nagai; Abraham Nyska; Yoshimasa Okazaki; Peter J Clements; Matthias Rinke; Paul W Snyder; Michael C Boyle; Monique Y Wells
Journal:  J Toxicol Pathol       Date:  2016-07-29       Impact factor: 1.628

Review 8.  Vascular complications after splenectomy for hematologic disorders.

Authors:  Shelley E Crary; George R Buchanan
Journal:  Blood       Date:  2009-07-27       Impact factor: 22.113

9.  Vascular dysfunction in a murine model of severe hemolysis.

Authors:  Anne C Frei; YiHe Guo; Deron W Jones; Kirkwood A Pritchard; Karen A Fagan; Neil Hogg; Nancy J Wandersee
Journal:  Blood       Date:  2008-05-13       Impact factor: 22.113

10.  Watershed Infarct in Beta-Thalassemia Major Patient.

Authors:  Behnaz Ansari; Mohammad Saadatnia; Ali Asghar Okhovat
Journal:  Case Rep Neurol Med       Date:  2017-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.